Digestive Cancers Europe - for Patients

Website

Digestive Cancers Europe - for Patients DiCE is a European non-profit umbrella organisation of nearly 40 national Member Organisations across Europe.
(1)

What if access to treatment wasn’t limited by cost, but by how we choose to organise our healthcare systems?Biosimilars ...
20/10/2026

What if access to treatment wasn’t limited by cost, but by how we choose to organise our healthcare systems?

Biosimilars are challenging that reality. By reducing the cost of biological treatments without compromising safety, quality, or effectiveness, they create space for healthcare systems to treat more patients and start therapies earlier.

But their impact goes beyond savings. They raise an important question: how do we translate financial efficiency into real equity, ensuring that patients, regardless of where they live, can access the care they need?

As healthcare budgets come under increasing pressure, biosimilars are not just an alternative; they test how we prioritise sustainability, fairness, and access in modern healthcare.

Today, on the third day of  , Juliana Calheiros and Marianna Vitaloni, from DiCE, presented findings from the togas.eupr...
19/10/2026

Today, on the third day of , Juliana Calheiros and Marianna Vitaloni, from DiCE, presented findings from the togas.euproject !

As part of this European initiative, DiCE contributed by gathering insights from the general public on the acceptability of future gastric cancer screening programmes across Europe.

Understanding public perspectives is essential to shaping screening strategies that are effective and aligned with people’s needs, expectations, and preferences.

UEG

Today, on the third day of  , Juliana Calheiros and Marianna Vitaloni, from DiCE, presented findings from the TOGAS EU p...
19/10/2026

Today, on the third day of , Juliana Calheiros and Marianna Vitaloni, from DiCE, presented findings from the TOGAS EU project!

As part of this European initiative, DiCE contributed by gathering insights from the general public on the acceptability of future gastric cancer screening programmes across Europe.

Understanding public perspectives is essential to shaping screening strategies that are effective and aligned with people's needs, expectations, and preferences.

fans UEG - United European Gastroenterology

🔬 Scientific breakthroughs alone do not change patient outcomes.Dr Benedikt Westphalen will be among the speakers at our...
19/10/2026

🔬 Scientific breakthroughs alone do not change patient outcomes.

Dr Benedikt Westphalen will be among the speakers at our upcoming DiCE Biomarkers Webinar, highlighting the importance of biomarker testing, clinical evidence, and equitable access to effective therapies that benefit patients.

Join us online as we explore how to turn scientific innovation into better, more accessible and sustainable cancer care.

🗓️ 12 November 2026 at 10:00 CET
💻 Online webinar
🔗 Register now: https://digestivecancers-eu.zoom.us/meeting/register/CN12Sa37Tp26vVf-45g3DA?fbclid=IwY2xjawVATSpleHRuA2FlbQIxMABwZG9mAWJyaWQRMHNrQkxrVVdrVlNrZ3dSVXlzcnRjBmFwcF9pZBAyMjIwMzkxNzg4MjAwODkyAAEeMqfq09joaW4DX2BFfWbGm-Q_37XKnQ4w5r4MuYJkUE7ZitdXOLDfP-LVNHc_aem_Megk605C2mHN6rgSHWcd5A #/registration

Today, at the start of Global Biosimilars Week, join us in raising awareness of biosimilars, a key innovation that helps...
19/10/2026

Today, at the start of Global Biosimilars Week, join us in raising awareness of biosimilars, a key innovation that helps make cancer care more accessible, sustainable, and equitable.

Biosimilars are highly similar versions of already approved biological medicines, with no clinically meaningful differences in safety, quality, or effectiveness. In Europe, the European Medicines Agency rigorously evaluates them, ensuring the same high standards as originator treatments.

Scientific evidence and real-world data consistently confirm that biosimilars are safe, effective, and interchangeable with their reference medicines.

This week, we will explore how biosimilars are transforming treatment across Europe and why they matter for patients, healthcare systems, and the future of care.

Today, during the 2nd day of   in Barcelona, UEG officially launched its new Patient Representatives Advisory Board (PRA...
18/10/2026

Today, during the 2nd day of in Barcelona, UEG officially launched its new Patient Representatives Advisory Board (PRAB), with Zorana Maravic joining as a representative of Digestive Cancers Europe.

Over the next three years, we will work with seven other European patient organisations, namely AOECS Gluten Free Alliance , ECPObesity, European Liver Patient's Asso , EOS Network - Eosinophilic Diseases Charity, Ifcca Ibd, International Liver Cancer Movement and Pancreatic Cancer Europe (PCE) , to ensure that patients’ voices and needs are meaningfully reflected across UEG’s policy, advocacy, research and educational activities.

Through this collaboration, DiCE will help bring the perspectives of people affected by digestive cancers into discussions on shared challenges, including prevention, early diagnosis, screening, access to care and patient-centred research.

👏 We welcome this important step towards closer collaboration among healthcare professionals, researchers and patient organisations. Patients should not only be heard but also actively involved in shaping decisions that affect their health and care.

DigestiveCancers

Today, during the 2nd day of   in Barcelona, UEG - United European Gastroenterology officially launched its new Patient ...
18/10/2026

Today, during the 2nd day of in Barcelona, UEG - United European Gastroenterology officially launched its new Patient Representatives Advisory Board (PRAB), with Zorana Maravic joining as a representative of Digestive Cancers Europe.

Over the next three years, we will work with seven other European patient organisations, namely Gluten Free Alliance, ECPObesity, European Liver Patients' Association, EOS Network - Eosinophilic Diseases Charity, IFCCA – International Federation of Crohn’s and Ulcerative Colitis Associations, International Liver Cancer Movement and PCE Pancreatic Cancer Europe, to ensure that patients' voices and needs are meaningfully reflected across UEG's policy, advocacy, research and educational activities.

Through this collaboration, DiCE will help bring the perspectives of people affected by digestive cancers into discussions on shared challenges, including prevention, early diagnosis, screening, access to care and patient-centred research.

👏 We welcome this important step towards closer collaboration among healthcare professionals, researchers and patient organisations. Patients should not only be heard but also actively involved in shaping decisions that affect their health and care.

fans

Today, DiCE CEO Zorana Maravic joined the PCE Pancreatic Cancer Europe meeting, “Pancreatic Cancer Primary Prevention an...
17/10/2026

Today, DiCE CEO Zorana Maravic joined the PCE Pancreatic Cancer Europe meeting, “Pancreatic Cancer Primary Prevention and Screening Interventions,” on day one in Barcelona!

In her presentation, “From Awareness to Action: Building Public-Health Policy for Pancreatic Cancer Prevention and Early Detection,” Zorana highlighted the urgent need for stronger public health action.

With most patients diagnosed at an advanced stage, pancreatic cancer remains a major public health challenge. While population-wide screening is not yet available, we can act now by raising awareness of modifiable risk factors, improving the identification and surveillance of people at high risk, and strengthening European collaboration and research to develop effective early-detection strategies.

A meaningful start to , with more discussions and opportunities for collaboration ahead. Stay tuned for updates!

fans UEG - United European Gastroenterology

Save the date for the 7th DiCE Colorectal Cancer Screening Summit, taking place online on 🗓️ 9 December 2026. This event...
17/10/2026

Save the date for the 7th DiCE Colorectal Cancer Screening Summit, taking place online on 🗓️ 9 December 2026. This event will gather experts, healthcare providers, policymakers, and patient advocates from across Europe.

Building on past Summits, it will focus on promoting effective, accessible, and sustainable colorectal cancer screening programs, reducing disparities, and increasing participation throughout Europe.

Through expert debates and shared experiences, the Summit aims to enhance prevention, enable earlier diagnosis, and improve outcomes for those at risk of colorectal cancer.

🔗 https://digestivecancers-eu.zoom.us/meeting/register/wVePIIrRT_2Z_sBqihpp3A?utm_source=ig&utm_medium=social&utm_content=link_in_bio&fbclid=PAZXh0bgNhZW0CMTEAcGRvZgJzcnRjBmFwcF9pZA85MzY2MTk3NDMzOTI0NTkAAad6EAOvCGYqTEvqzHN_oCUre1Hehl0hG6-OajSQJJxwyrHd52JAsnGSngoTyw_aem_EidAfwHR9BwIT1LGiBm8AA #/registration

fans EU Science & Innovation EU Science Hub - Joint Research Centre Colon Cancer Coalition Europa Colon Slovenija Global Colon Cancer Association

The DiCE team is ready to welcome you to our booth in the community area at   in Barcelona!Stop by to meet us, learn mor...
17/10/2026

The DiCE team is ready to welcome you to our booth in the community area at in Barcelona!

Stop by to meet us, learn more about our work in digestive cancer prevention, research and patient advocacy, and discover how we’re bringing the patient voice into European research projects.

Whether you’re a healthcare professional, researcher, patient advocate or simply interested in our work, we’d love to connect, exchange ideas and explore opportunities for collaboration.

See you at our booth!

fans UEG - United European Gastroenterology

Adres

Rue De La Loi 235
Brussels
1040

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Digestive Cancers Europe - for Patients nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Snelkoppelingen

Delen

Categorie